FindTrial
Sign In

The role of GDF15 in evaluating the prognosis of critically ill patients

The role of GDF15 in evaluating the prognosis of critically ill patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090770
Enrollment
Unknown
Registered
2024-10-12
Start date
2023-03-01
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical disease

Interventions

Development Cohort:N/A

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria 1) Age = 18 years old 2) Admission to the intensive care unit 3) Infected or suspected infected patients have a qSOFA score of = 2

Exclusion criteria

Exclusion criteria: 2. Exclusion criteria 1) Age<18 years old 2) The patient refused to participate in the study 3) Previously participated in this study

Design outcomes

Primary

MeasureTime frame
Serum Growth differentiation factor 15;28-day all-cause mortality;—

Secondary

MeasureTime frame
7-day all-cause mortality;90-day all-cause mortality;180-day all-cause mortality;ICU length of stay;Mechanical ventilation time;The occurrence of cardiovascular events during hospitalization;APACHEII score;SOFA score;—

Countries

China

Contacts

Public ContactHan Yi

Jiangsu Province Hospital

hanyi@jsph.org.cn+86 139 1399 5518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026